The mechanism of EPO-EPOR and HER2 co-regulation in breast cancer was confirmed by miR-125b, which is downregulated in metastatic breast cancers and a significant positive correlation between EPOR and HER2 levels that are both targets of miR-125b was demonstrated (94). This evidence concerns the gene ERBB2 and breast carcinoma.